NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Naloxone Hydrochloride And Pentazocine Hydrochloride patents expire, and when can generic versions of Naloxone Hydrochloride And Pentazocine Hydrochloride launch?
Naloxone Hydrochloride And Pentazocine Hydrochloride is a drug marketed by Lupin, Sun Pharm Inds Ltd, and Watson Labs. and is included in three NDAs.
The generic ingredient in NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE is naloxone hydrochloride; pentazocine hydrochloride. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride; pentazocine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Naloxone Hydrochloride And Pentazocine Hydrochloride
A generic version of NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE was approved as naloxone hydrochloride; pentazocine hydrochloride by WATSON LABS on January 21st, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE?
- What are the global sales for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE?
- What is Average Wholesale Price for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE?
Summary for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 3 |
| Clinical Trials: | 2 |
| DailyMed Link: | NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute on Aging (NIA) | Phase 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 1 |
| Office of Research on Women's Health (ORWH) | Phase 1 |
See all NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE clinical trials
Pharmacology for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
| Drug Class | Opioid Antagonist Partial Opioid Agonist/Antagonist |
| Mechanism of Action | Competitive Opioid Antagonists Opioid Antagonists Partial Opioid Agonists |
US Patents and Regulatory Information for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin | NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE | naloxone hydrochloride; pentazocine hydrochloride | TABLET;ORAL | 075735-001 | Jul 11, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Inds Ltd | NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE | naloxone hydrochloride; pentazocine hydrochloride | TABLET;ORAL | 075523-001 | Mar 17, 2000 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE | naloxone hydrochloride; pentazocine hydrochloride | TABLET;ORAL | 074736-001 | Jan 21, 1997 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
